Literature DB >> 15195693

The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes.

Marta Benczik1, Sarah L Gaffen.   

Abstract

Lymphocyte populations in the immune system are maintained by a well-organized balance between cellular proliferation, cellular survival and programmed cell death (apoptosis). One of the primary functions of many cytokines is to coordinate these processes. In particular, the interleukin (IL)-2 family of cytokines, which consists of six cytokines (IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21) that all share a common receptor subunit (gammac), plays a major role in promoting and maintaining T lymphocyte populations. The details of the molecular signaling pathways mediated by these cytokines have not been fully elucidated. However, the three major pathways clearly involved include the JAK/STAT, MAPK and phosphatidylinositol 3-kinase (P13K) pathways. The details of these pathways as they apply to the IL-2 family of cytokines is discussed, with a focus on their roles in proliferation and survival signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195693     DOI: 10.1081/imm-120030732

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  43 in total

1.  Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.

Authors:  Christine Vogtenhuber; Christoph Bucher; Steven L Highfill; Lisa K Koch; Emily Goren; Angela Panoskaltsis-Mortari; Patricia A Taylor; Michael A Farrar; Bruce R Blazar
Journal:  Blood       Date:  2010-05-04       Impact factor: 22.113

2.  SDF-1α degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory.

Authors:  Sergey A Trushin; Alberto A Carena; Gary D Bren; Stacey A Rizza; Xiangyang Dong; Roshini S Abraham; Andrew D Badley
Journal:  J Immunol       Date:  2012-07-16       Impact factor: 5.422

3.  Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors.

Authors:  David Shasha; Dan Karel; Olivia Angiuli; Adam Greenblatt; Musie Ghebremichael; Xu Yu; Filippos Porichis; Bruce D Walker
Journal:  J Leukoc Biol       Date:  2016-07-12       Impact factor: 4.962

4.  Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model.

Authors:  Antonio Pinto; Annika Jahn; Moritz Benjamin Immohr; Alexander Jenke; Laura Döhrn; Markus Kornfeld; Artur Lichtenberg; Payam Akhyari; Udo Boeken
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

Review 5.  Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.

Authors:  Christian Fercher; Sahar Keshvari; Michael A McGuckin; Ross T Barnard
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-19

6.  PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.

Authors:  Felicita Baratelli; Jay M Lee; Saswati Hazra; Ying Lin; Tonya C Walser; Dorthe Schaue; Peter S Pak; David Elashoff; Karen Reckamp; Ling Zhang; Michael C Fishbein; Sherven Sharma; Steven M Dubinett
Journal:  Am J Transl Res       Date:  2010-06-30       Impact factor: 4.060

7.  Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation.

Authors:  L L Santos; A Dacumos; J Yamana; L Sharma; E F Morand
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

8.  Death pathways in T cell homeostasis and their role in autoimmune diabetes.

Authors:  Matthew A Gronski; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2006-08-10

9.  PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity.

Authors:  Irina V Pinchuk; Jamal I Saada; Ellen J Beswick; Gushyalatha Boya; Sumin M Qiu; Randy C Mifflin; Gottumukkala S Raju; Victor E Reyes; Don W Powell
Journal:  Gastroenterology       Date:  2008-07-17       Impact factor: 22.682

10.  Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy.

Authors:  Danielle R Bruns; Peter M Buttrick; Lori A Walker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.